|
paxil drug interaction O 72 years) treated with PAXIL CR who participated in short-term (10-week) placebo-controlled trials in panic disorder in which patients were dosed in a range of 12.5 mg to 75 mg day. Table 4 enumerates adverse events reported at an incidence of 1% or greater among adult patients treated with PAXIL CR who participated in a short-term (12-week) paxil drug interaction, double-blind paxil drug interaction, placebo-controlled trial in social anxiety disorder in which patients were dosed in a range of 12.5 to 37.5 mg day. Table 5 enumerates adverse events that occurred at an incidence of 1% or more among patients treated with PAXIL CR who participated in three paxil drug interaction, 12-week paxil drug interaction, placebo-controlled trials in PMDD in w paxil drug interaction.
paxil drug interaction Hich patients were dosed at 12.5 mg day or 25 mg day and in one 12-week placebo-controlled trial in which patients were dosed for 2 weeks prior to the onset of menses (luteal phase dosing) at 12.5 mg day or 25 mg day. Reported adverse events were classified using a standard COSTART-based Dictionary terminology. The prescriber should be aware that these figures cannot be used to predict the incidence of side effects in the course of usual medical practice where patient characteristics and other factors differ from those that prevailed in the clinical trials. Similarly paxil drug interaction, the cited frequencies cannot be compared with figures obtained from other clinical investigations involving different treatments paxil drug interaction, uses paxil drug interaction, and investigators. The cited figures paxil drug interaction, however paxil drug interaction, do provide the prescribing physician with some basis for estimating the relative contribution of drug and nondrug factors to the side effect incidence rate in the population studied. Table 1. Treatment-Emergent Adverse Events Occurring in & 179; 1% of Patients Treated With PAXIL CR in a Pool of 2 Studies in Major Depressive Disorder1 paxil drug interaction, 2 Body System Adverse Event % Reporting Event PAXIL CR (n = 212) Placebo (n = 211) Body as a Whole Headache 27% 20% Asthenia 14% 9% Infection3 8% 5% Abdominal Pain 7% 4% Back Pain 5% 3% Trauma4 5% 1% Pain5 3% 1% Allergic Reaction6 2% 1% Ca.
paxil drug interaction Tions involving different treatments paxil drug interaction, uses paxil drug interaction, and investigators. The cited figures paxil drug interaction, however paxil drug interaction, do provide the prescribing physician with some basis for estimating the relative contribution of drug and nondrug factors to the side effect incidence rate in the population studied. Table 1. Treatment-Emergent Adverse Events Occurring in & 179; 1% of Patients Treated With PAXIL CR in a Pool of 2 Studies in Major Depressive Disorder1 paxil drug interaction, 2 Body System Adverse Event % Reporting Event PAXIL CR (n = 212) Placebo (n = 211) Body as a Whole Headache 27% 20% Asthenia 14% 9% Infection3 8% 5% Abdominal Pain 7% 4% Back Pain 5% 3% Trauma4 5% 1% Pain5 3% 1% Allergic Reaction6 2% 1% Car.
paxil drug interaction 
paxil drug interaction | | | | | |
paxil drug interaction
|
